Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists
Published on: August 11, 2023
Paediatric antiepileptic polytherapy: systematic review of efficacy and neurobehavioural effects and a tertiary
D Plevin1, J Jureidini2,3, S Howell4
1Flinders Medical Centre, Bedford Park, SA, Australia.
Insights
Antiepileptic polytherapy is common in pediatric epilepsy patients but lacks evidence of efficacy. Clinicians should weigh potential neurobehavioral harms against seizure control benefits.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Antiepileptic polytherapy is frequently used in children with epilepsy.
- Limited evidence exists regarding its efficacy and neurobehavioral safety.
Purpose of the Study:
- To determine the prevalence of antiepileptic polytherapy in a pediatric tertiary care setting.
- To systematically review the evidence on the efficacy and neurobehavioral safety of antiepileptic polytherapy in children.
Main Methods:
- Prevalence assessed via pharmacy dispensing records.
- Neurobehavioral comorbidities reviewed from patient records.
- Systematic literature review conducted for safety and efficacy data.
Main Results:
- Polytherapy was prescribed to 44.7% of pediatric epilepsy patients.
- Patients with intellectual disability were more likely to receive polytherapy.
- No trials directly assessed polytherapy efficacy; observational studies linked it to adverse neurobehavioral outcomes.
Conclusions:
- Antiepileptic polytherapy is prevalent in pediatric epilepsy but lacks supporting efficacy evidence.
- Randomized controlled trials are challenging in this population.
- Potential neurobehavioral adverse effects may outweigh seizure control benefits.
Aim:
This paper presents the prevalence of antiepileptic polytherapy at a single tertiary institution and systematically reviews the evidence base for its efficacy and neurobehavioural safety in children.
Method:
Prevalence of antiepileptic polypharmacy was determined from pharmacy dispensing records at a paediatric tertiary hospital and neurobehavioural comorbidities quantified through casenote review; comparison is made with studies evaluating the neurobehavioural safety of antiepileptic polytherapy, identified via systematic literature review.
Results:
Amongst 262 patients at the hospital, 117 (44.7%) were prescribed polytherapy; with patients having an intellectual disability statistically more likely to be prescribed polytherapy than those without (70.5% vs 40.6%; p < 0.0001). Systematic review identified no trials addressing the efficacy or neurobehavioural outcomes of polytherapy as a primary outcome. Several observational studies identified associations between polytherapy and neurobehavioural adverse outcomes such as anxiety and behavioural disturbance. Observational studies also suggest that a reduction in polytherapy load is generally not associated with worsening seizure control.
Conclusion:
Whilst antiepileptic polytherapy is common practice within paediatric epilepsy cohorts attending tertiary care institutions, evidence is lacking to support its efficacy. There are significant practical difficulties to undertaking randomised controlled trials within this population. Nonetheless, clinicians must consider that adverse neurobehavioural consequences of polytherapy might outweigh benefits to seizure control.
Related Concept Videos
Tertiary Healthcare System
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Antiepileptic Drugs: Glutamate Antagonists
Nomenclature of Secondary and Tertiary Amines
Self-Efficacy

